Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
boston top stories
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
deals
medical devices
new york blog main
new york top stories
san francisco
startups
accelerator
airbnb
alphabet
amazon web services (aws)
amgen
artificial intelligence (a.i.)
athelas
atomwise
benchling
biotech
biotechnology
broad institute of harvard and mit
brook byers
cancer
charles chu
cholesterol
clinical trials
coinbase
coworking
crispr
crispr cas14
cruise
culture biosciences
data
data analytics
decheng capital
detroit blog main
What
big
3
×
aces
admits
ago
announced
available
based
bio
biosciences
biotechs
cas
ceo
cheaper
cholesterol
classes
combinator
companies
crispr
develop
diagnostics
drug
dug
expects
faster
flexible
inclisiran
incubator
key
life
lowering
mammoth
meant
medco
medicine
medicines
nasdaq
open
passed
previously
pricing
Language
unset
3
×
Current search:
big
×
unset
×
" boston blog main "
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
